US Stock MarketDetailed Quotes

Xilio Therapeutics (XLO)

Watchlist
  • 8.690
  • +0.190+2.24%
Close Apr 8 16:00 ET
  • 8.690
  • 0.0000.00%
Post 17:52 ET
50.25MMarket Cap-2.07P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xilio Therapeutics (XLO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
589.88%43.77M
693.85%13.69M
742.51%19.07M
242.98%8.08M
2.93M
6.34M
1.72M
2.26M
2.36M
0
Operating revenue
589.88%43.77M
693.85%13.69M
742.51%19.07M
242.98%8.08M
--2.93M
--6.34M
--1.72M
--2.26M
--2.36M
--0
Cost of revenue
Gross profit
Operating expense
29.94%85.75M
66.23%25.52M
23.02%21M
31.82%22.45M
1.46%16.78M
-16.61%65.99M
-15.32%15.35M
-1.70%17.07M
-15.34%17.03M
-29.70%16.54M
Selling and administrative expenses
19.90%29.71M
13.55%7.4M
5.82%6.67M
22.44%7.12M
38.70%8.52M
-8.22%24.78M
1.92%6.52M
-0.05%6.31M
-15.70%5.82M
-16.98%6.14M
-General and administrative expense
19.90%29.71M
13.55%7.4M
5.82%6.67M
22.44%7.12M
38.70%8.52M
-8.22%24.78M
1.92%6.52M
-0.05%6.31M
-15.70%5.82M
-16.98%6.14M
Research and development costs
35.98%56.04M
105.09%18.12M
33.11%14.32M
36.68%15.33M
-20.52%8.27M
-20.95%41.21M
-24.71%8.84M
-2.64%10.76M
-15.15%11.22M
-35.53%10.4M
Operating profit
29.61%-41.98M
13.16%-11.84M
86.97%-1.93M
2.10%-14.37M
16.25%-13.85M
24.63%-59.65M
24.83%-13.63M
14.73%-14.8M
27.05%-14.67M
29.70%-16.54M
Net non-operating interest income expense
Other net income (expense)
394.73%6.95M
4,041.04%22.2M
-1,933.72%-14.36M
-297.33%-1.48M
188.25%586K
-48.55%1.4M
12.84%536K
27.73%783K
-1.58%749K
-175.45%-664K
Gain on sale of security
--5.85M
--21.28M
---15.38M
---50K
----
----
----
----
----
----
Special income (charges)
--0
--0
--0
--0
--0
---937K
--0
--41K
---30K
---948K
-Less：Restructuring and merger&acquisition
--0
--0
--0
--0
--0
--937K
--0
---41K
--30K
--948K
Other non- operating income (expenses)
-52.97%1.1M
71.83%921K
37.74%1.02M
-283.31%-1.43M
106.34%586K
-14.22%2.34M
12.84%536K
21.04%742K
2.37%779K
-67.73%284K
Income before tax
39.84%-35.04M
179.13%10.36M
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
23.77%-58.24M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
24.04%-17.2M
Income tax
Net income
39.84%-35.04M
179.13%10.36M
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
23.77%-58.24M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
24.04%-17.2M
Net income continuous Operations
39.84%-35.04M
179.13%10.36M
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
23.77%-58.24M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
24.04%-17.2M
Minority interest income
Net income attributable to the parent company
39.84%-35.04M
179.13%10.36M
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
23.77%-58.24M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
24.04%-17.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
39.84%-35.04M
179.13%10.36M
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
23.77%-58.24M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
24.04%-17.2M
Basic earnings per share
-284.91%-58.66
580.00%13.44
50.00%-1.54
33.33%-2.24
70.97%-2.52
60.84%-15.24
68.75%-2.8
63.93%-3.08
65.71%-3.36
25.30%-8.68
Diluted earnings per share
-284.91%-58.66
505.00%11.34
50.00%-1.54
33.33%-2.24
70.97%-2.52
60.84%-15.24
68.75%-2.8
63.93%-3.08
65.71%-3.36
25.30%-8.68
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 589.88%43.77M693.85%13.69M742.51%19.07M242.98%8.08M2.93M6.34M1.72M2.26M2.36M0
Operating revenue 589.88%43.77M693.85%13.69M742.51%19.07M242.98%8.08M--2.93M--6.34M--1.72M--2.26M--2.36M--0
Cost of revenue
Gross profit
Operating expense 29.94%85.75M66.23%25.52M23.02%21M31.82%22.45M1.46%16.78M-16.61%65.99M-15.32%15.35M-1.70%17.07M-15.34%17.03M-29.70%16.54M
Selling and administrative expenses 19.90%29.71M13.55%7.4M5.82%6.67M22.44%7.12M38.70%8.52M-8.22%24.78M1.92%6.52M-0.05%6.31M-15.70%5.82M-16.98%6.14M
-General and administrative expense 19.90%29.71M13.55%7.4M5.82%6.67M22.44%7.12M38.70%8.52M-8.22%24.78M1.92%6.52M-0.05%6.31M-15.70%5.82M-16.98%6.14M
Research and development costs 35.98%56.04M105.09%18.12M33.11%14.32M36.68%15.33M-20.52%8.27M-20.95%41.21M-24.71%8.84M-2.64%10.76M-15.15%11.22M-35.53%10.4M
Operating profit 29.61%-41.98M13.16%-11.84M86.97%-1.93M2.10%-14.37M16.25%-13.85M24.63%-59.65M24.83%-13.63M14.73%-14.8M27.05%-14.67M29.70%-16.54M
Net non-operating interest income expense
Other net income (expense) 394.73%6.95M4,041.04%22.2M-1,933.72%-14.36M-297.33%-1.48M188.25%586K-48.55%1.4M12.84%536K27.73%783K-1.58%749K-175.45%-664K
Gain on sale of security --5.85M--21.28M---15.38M---50K------------------------
Special income (charges) --0--0--0--0--0---937K--0--41K---30K---948K
-Less：Restructuring and merger&acquisition --0--0--0--0--0--937K--0---41K--30K--948K
Other non- operating income (expenses) -52.97%1.1M71.83%921K37.74%1.02M-283.31%-1.43M106.34%586K-14.22%2.34M12.84%536K21.04%742K2.37%779K-67.73%284K
Income before tax 39.84%-35.04M179.13%10.36M-16.17%-16.29M-13.78%-15.84M22.89%-13.27M23.77%-58.24M25.84%-13.09M16.29%-14.02M28.05%-13.93M24.04%-17.2M
Income tax
Net income 39.84%-35.04M179.13%10.36M-16.17%-16.29M-13.78%-15.84M22.89%-13.27M23.77%-58.24M25.84%-13.09M16.29%-14.02M28.05%-13.93M24.04%-17.2M
Net income continuous Operations 39.84%-35.04M179.13%10.36M-16.17%-16.29M-13.78%-15.84M22.89%-13.27M23.77%-58.24M25.84%-13.09M16.29%-14.02M28.05%-13.93M24.04%-17.2M
Minority interest income
Net income attributable to the parent company 39.84%-35.04M179.13%10.36M-16.17%-16.29M-13.78%-15.84M22.89%-13.27M23.77%-58.24M25.84%-13.09M16.29%-14.02M28.05%-13.93M24.04%-17.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 39.84%-35.04M179.13%10.36M-16.17%-16.29M-13.78%-15.84M22.89%-13.27M23.77%-58.24M25.84%-13.09M16.29%-14.02M28.05%-13.93M24.04%-17.2M
Basic earnings per share -284.91%-58.66580.00%13.4450.00%-1.5433.33%-2.2470.97%-2.5260.84%-15.2468.75%-2.863.93%-3.0865.71%-3.3625.30%-8.68
Diluted earnings per share -284.91%-58.66505.00%11.3450.00%-1.5433.33%-2.2470.97%-2.5260.84%-15.2468.75%-2.863.93%-3.0865.71%-3.3625.30%-8.68
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.68%
Sample Name
Sample Code
 +16.26%
Sample Name
Sample Code
 +13.08%
4
United Sts Brent Oil Fd Lp Unit
BNO
+10.72%
5
ProShares Ultra Energy
DIG
+9.35%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.90%
Sample Name
Sample Code
 +14.44%
Sample Name
Sample Code
 +13.72%
4
ASE Technology
ASX
+11.35%
5
Kingsoft Cloud
KC
+9.51%
View More
Middle East conflict spreads to the stock market! How should investors respond?
A major turning point has emerged in the US-Iran situation! Trump announced a two-week suspension of military action against Iran, and both Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -